期刊文献+

PET-CT在淋巴瘤患者放化疗后判断疗效的应用 被引量:1

下载PDF
导出
摘要 目的:分析PET-CT在淋巴瘤患者放化疗后判断疗效的应用效果。方法:撷取本院收治的30例淋巴瘤患者,撷取时间是自2012年4月—2017年4月,分组原则以抽签法为主,分研究组(n=15)和对照组(n=15)。对照组在治疗后予以PET-CT显像,研究组在治疗前后均予以PET-CT显像。比较两组疗效以及显像情况。结果:与对照组疗效(46.7%)比较,研究组的(86.7%)较高,优势突出,P<0.05;研究组治疗前的SUVmax平均值远比治疗后的高,差异突出,P<0.05;研究组治疗后的SUVmax平均值远比对照组治疗后的高,差异突出,P<0.05。结论:淋巴瘤患者在化疗期间予以PET-CT检查,可有效提高化疗效果,判断残余的病灶是否复发,为临床医师诊断患者疾病提供一定的可靠依据,进一步保证化疗、放疗效果,改善预后,值得借鉴。
出处 《影像研究与医学应用》 2017年第18期102-104,共3页 Journal of Imaging Research and Medical Applications
  • 相关文献

参考文献8

二级参考文献78

  • 1邱琰,郭睿,胡佳佳,王超,江旭峰,张敏,张淼,李彪.胃部惰性淋巴瘤与侵袭性淋巴瘤的^(18)F-FDG PET/CT表现[J].肿瘤影像学,2013,22(3):203-206. 被引量:3
  • 2乔文礼,赵晋华,王椿,何之彦,汪太松,邢岩.^(18)F-FDG符合探测显像与CT显像在淋巴瘤分期和疗效评价中的比较[J].中华肿瘤杂志,2007,29(7):536-539. 被引量:8
  • 3Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?[J]. Ann Oneol, 2006, 17( 1 ): 117-122.
  • 4Polosi E, Perma D, Douroukas A, et al. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multieentre study[J]. Q J Nucl Med Mol Imaging, 2011, 55(4): 469-475.
  • 5Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of Imaging Subcommittee of International Harmonization Project in lymphoma[J]. J Clin Oncol, 2007, 25 (5): 571-578.
  • 6Dupuis J, Itti E, Rahmouni A, et al. Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphorna: integrating 18ftuorodeoxyglucose positron emission tomography to the International Workshop Criteria[J]. Ann Oncol, 2009, 20 (3): 503-507.
  • 7Thomas A, Gingrich RD, Smith B J, et al. ^38F-Fluoro- deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reports [J]. Leuk Lymphoma, 2010, 51 (3): 439-446.
  • 8Mikhaeel NG. Interim Fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B-cell lymphoma: where are we know? [J]. Leuk Lymphoma, 2009, 50 (12): 1931-1936.
  • 9Chow A, Phillips M, Siew T, et al. Prognostic nomogram for diffuse large B-cell lymphoma (DLBCL) incorporating the International Prognostic Index (IPI) with interim-positron emission tomography (interim-PET) findings [J]. Inter Med J, 2013, 43(8): 932-939.
  • 10Yang DH, Min JJ, Song HC, et al. Prognostic significance of interim ^18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma [J]. Eur J Cancer, 2011, 47(9): 1312-1318.

共引文献46

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部